Literature DB >> 8269629

Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers.

J K Vishwanatha1, Y Chiang, K D Kumble, M A Hollingsworth, P M Pour.   

Abstract

Annexin II is a calcium and phospholipid binding protein and a substrate for protein-tyrosine kinases. Recent investigations have revealed involvement of annexin II in DNA synthesis and cell proliferation. Increased levels of annexin II are observed in cancer cells and tissues. To investigate the expression of annexin II in pancreatic adenocarcinoma cells and primary tumors, we measured the levels of annexin II mRNA and protein in normal human pancreas, five established human pancreatic adenocarcinoma cell lines, three primary pancreatic cancers and one metastatic tumor. All five cell lines examined had 5- to 15-fold higher levels of annexin II as compared to normal pancreas. Significant elevations (2- to 8-fold) of annexin II expression were observed in the three primary pancreatic tumors and one metastatic tumor examined. Immunocytochemical analysis indicates that the increased expression of annexin II is limited to proliferating ductular adenocarcinoma, and annexin II expression co-localizes with cells that express PCNA. In normal pancreas, annexin II expression is seen in ductal and ductular cells and no expression is seen in acinar or islet cells. We conclude from these findings that annexin II has a role in cell proliferation and its regulation is altered in pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8269629     DOI: 10.1093/carcin/14.12.2575

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  45 in total

1.  Specific down-regulation of annexin II expression in human cells interferes with cell proliferation.

Authors:  Y Chiang; A Rizzino; Z A Sibenaller; M S Wold; J K Vishwanatha
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

2.  Annexin II is associated with mRNAs which may constitute a distinct subpopulation.

Authors:  A Vedeler; H Hollås
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

3.  Quantitative proteomic analysis identifying three annexins as lymph node metastasis-related proteins in lung adenocarcinoma.

Authors:  Ying-Fu Liu; Yong-Heng Chen; Mao-Yu Li; Peng-Fei Zhang; Fang Peng; Guo-Qing Li; Zhi-Qiang Xiao; Zhu-Chu Chen
Journal:  Med Oncol       Date:  2010-12-04       Impact factor: 3.064

4.  Involvement of Annexin A2 in p53 induced apoptosis in lung cancer.

Authors:  Yun Huang; Yan Jin; Cheng-Hui Yan; Yang Yu; Jing Bai; Feng Chen; Yu-Zhen Zhao; Song-Bin Fu
Journal:  Mol Cell Biochem       Date:  2007-11-16       Impact factor: 3.396

5.  Pathological findings in a case of bone marrow carcinosis due to gastric cancer complicated by disseminated intravascular coagulation and thrombotic microangiopathy.

Authors:  Yoshinobu Seki; Kunihiko Wakaki
Journal:  Int J Hematol       Date:  2016-06-29       Impact factor: 2.490

6.  Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.

Authors:  Jocelyn Stewart; Neil Fleshner; Heather Cole; Joan Sweet
Journal:  J Clin Pathol       Date:  2006-08-17       Impact factor: 3.411

7.  ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer.

Authors:  Nicholas B Griner; Denise Young; Pankaj Chaudhary; Ahmed A Mohamed; Wei Huang; Yongmei Chen; Taduru Sreenath; Albert Dobi; Gyorgy Petrovics; Jamboor K Vishwanatha; Isabell A Sesterhenn; Shiv Srivastava; Shyh-Han Tan
Journal:  Mol Cancer Res       Date:  2014-10-24       Impact factor: 5.852

8.  Prognostic significance of annexin II expression in non-small cell lung cancer.

Authors:  C-H Luo; Q-Q Liu; P-F Zhang; M-Y Li; Z-C Chen; Y-F Liu
Journal:  Clin Transl Oncol       Date:  2013-03-26       Impact factor: 3.405

9.  Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro.

Authors:  V M Díaz; M Hurtado; T M Thomson; J Reventós; R Paciucci
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

10.  Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2.

Authors:  Elena Ortiz-Zapater; Sandra Peiró; Oriol Roda; Josep M Corominas; Susana Aguilar; Coral Ampurdanés; Francisco X Real; Pilar Navarro
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.